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Abstract: We present a case of an 18-year-old male patient who, after two years of inappropriate treatment for
cutaneous leishmaniasis, began to show nodules arising at the edges of the former healing scar. He was immune
competent and denied any trauma. The diagnosis of  recurrent cutaneous leishmaniasis was made following pos-
itive culture of aspirate samples. The patient was treated with N-methylglucamine associated with pentoxifylline
for 30 days. Similar cases require special attention mainly because of the challenges imposed by treatment.
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Resumo: Paciente do sexo masculino, 18 anos. Dois anos após tratamento insuficiente para leishmaniose tegu-
mentar americana, apresentou, na mesma localização, lesão formada por cicatriz atrófica central e nódulos ver-
rucosos na periferia. Era imunocompetente, hígido e negava qualquer trauma local. O diagnóstico de leishma-
niose recidiva cutis foi feito através de cultura do aspirado da lesão. Realizou tratamento com N-metilglucami-
na (20mgSbV/kg/dia) associado à pentoxifilina (1200mg/dia) durante 30 dias alcançando cura clínica. Os casos
semelhantes requerem atenção diferenciada pela dificuldade ao tratamento.
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Report
We present a case of an 18-year-old male patient
from the northeast of Brazil. He had experienced an
ulcer on the anterior face of his left thigh which was
treated as American Cutaneous Leishmaniasis (ACL).
The use of N-methylglucamine (7mgSbV/Kg/day) for
20 days ensured complete healing. However verrucous
nodules began to appear at the periphery of the former
atrophic scar two years after clinical cure (Figures 1 and
2). The patient presented no immunodeficiency.
A positive (6x5mm) Montenegro intradermore-
action was found, in addition to high titer (1:160) of
anti-ACL antibodies showed by indirect immunofluo-
rescence. The smear was negative, together with the
cultures for mycobacteria and fungus. Histological
examination showed pseudoepitheliomatous hyper-
plasia and linfohistioplasmocitoid granulomas
(Figure 3). 
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The diagnosis of Recurrent Cutaneous
Leishmaniasis (RCL) was confirmed after the positive
culture of aspirate specimens using the McNeal, Novy
& Nicolle culture medium.1 The species L. (V.)
braziliensis2 is endemic to the area of Brazil where the
patient originated. 
We decided to associate N-methylglucamine
(20mgSbV/kg/day) with pentoxifylline (1200mg/day)
for 30 days. 3,4 The patient achieved a long-term clini-
cal cure, observed over a 3-year follow-up period.
RCL is rare, usually occurring within two years
following the appearance of initial lesions. It is consid-
ered by many authors to be the result of inappropriate
treatment.5,6 Given the challenge of RCL we need to
consider long-term follow-up of all cases which
apparently have been wrongly treated.3,4,7 Using an
association of pentoxifylline in the treatment regime
was effective probably due to its immunomodulatory




















FIGURE 3: Hematoxiciline and eosine stain - 40x: Histopathological
examination with marked pseudoepitheliomatous hiperlasia and
extensive dermal inflammatory infiltrate
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